Shunli Cai , Qingyi Luo , Guozhong Zhou , Xin Guo , Yan Dong , Hongbo Chen , Shiqi Luo , Jian He , Yuan Xia , Hanse Li , Yingchen Zhou , Chao Song
{"title":"卡介苗-谷氨酰胺疫苗预防儿童结核分枝杆菌感染的效果:一项最新的系统评价和荟萃分析","authors":"Shunli Cai , Qingyi Luo , Guozhong Zhou , Xin Guo , Yan Dong , Hongbo Chen , Shiqi Luo , Jian He , Yuan Xia , Hanse Li , Yingchen Zhou , Chao Song","doi":"10.1016/j.ijid.2025.107909","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the <em>I²</em> statistic.</div></div><div><h3>Results</h3><div>Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], <em>I²</em> = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], <em>I²</em> = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], <em>I²</em> = 55%) in high-TB incidence areas.</div></div><div><h3>Conclusions</h3><div>BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"156 ","pages":"Article 107909"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis\",\"authors\":\"Shunli Cai , Qingyi Luo , Guozhong Zhou , Xin Guo , Yan Dong , Hongbo Chen , Shiqi Luo , Jian He , Yuan Xia , Hanse Li , Yingchen Zhou , Chao Song\",\"doi\":\"10.1016/j.ijid.2025.107909\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the <em>I²</em> statistic.</div></div><div><h3>Results</h3><div>Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], <em>I²</em> = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], <em>I²</em> = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], <em>I²</em> = 55%) in high-TB incidence areas.</div></div><div><h3>Conclusions</h3><div>BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.</div></div>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":\"156 \",\"pages\":\"Article 107909\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1201971225001328\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225001328","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis
Objectives
To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.
Methods
PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the I² statistic.
Results
Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], I² = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], I² = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], I² = 55%) in high-TB incidence areas.
Conclusions
BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.